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Abstract
Background: Increased consumption of linoleic acid (LA, omega-6) in Western diets coupled with the pro-
inflammatory and adipogenic properties of its derivatives has led to suggestions that fetal exposure to this
dietary pattern could be contributing to the intergenerational cycle of obesity.
Method: This study aimed to evaluate the effects of maternal consumption of a LA to alpha-linolenic acid
(ALA) ratio similar to modern Western diets (9:1) compared to a lower ratio (1:1.5) on placental and fetal
growth, and to determine any cumulative effects by feeding both diets at two total fat levels (18% vs 36%
fat w/w). Female Wistar rats (n = 5–7/group) were assigned to one of the four experimental diets prior to
mating until 20d of gestation.
Results: Fatty acid profiles of maternal and fetal blood and placental tissue at 20d gestation were different
between dietary groups, and largely reflected dietary fatty acid composition. Female fetuses were heavier (2.98 ± 0.06 g
vs 3.36 ± 0.07 g, P < 0.01) and male placental weight was increased (0.51 ± 0.02 g vs 0.58 ± 0.02 g, P < 0.05) in the low
LA:ALA groups. Female fetuses of dams exposed to a 36% fat diet had a reduced relative liver weight irrespective of LA:
ALA ratio (7.61 ± 0.22% vs 6.93 ± 0.19%, P < 0.05). These effects occurred in the absence of any effect of the dietary
treatments on maternal bodyweight, fat deposition or expression of key lipogenic genes in maternal and fetal liver or
maternal adipose tissue.
Conclusion: These findings suggest that both the total fat content as well as the LA:ALA ratio of the maternal diet
have sex-specific implications for the growth of the developing fetus.
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Introduction
The prevalence of obesity, a major risk factor for cardio-
vascular disease and type 2 diabetes, continues to rise in
both low-, middle- and high-income countries, with 1.9
billion adults worldwide estimated to be overweight or
obese as of 2016 [1]. Of particular concern is that 41
million children under the age of 5 were estimated to be
overweight or obese globally in 2016 [1], and often
present with early onset of cardiometabolic diseases
including type 2 diabetes and hypertension [2, 3].
Exposure to either an inappropriately high or in-
appropriately low plane of nutrition before birth and/
or in early infancy is a major risk factor for the de-
velopment of obesity and type 2 diabetes through the
life course [4–7]. Maternal high-fat diets have consist-
ently been associated with an increased risk of obesity
and poor cardiometabolic health in the offspring [8].
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It is increasingly recognised, however, that the impact
of maternal fat consumption is dependent not only
on the amount of fat consumed but also the specific
fat type. The ratio of omega-6 and omega-3 polyun-
saturated fatty acids (PUFA) in the diet appears to be
of particular importance, likely due to the opposing
roles of these two classes of PUFA on metabolic and
inflammatory processes within the body [9]. Thus,
omega-3 PUFA, including alpha-linolenic acid (ALA)
and its long chain PUFA (LCPUFA) derivatives, ei-
cosapentaenoic acid (EPA) and docosahexaenoic acid
(DHA) inhibit inflammation, adipogenesis and lipo-
genesis [10, 11]. Conversely, the omega-6 PUFA, lino-
leic acid (LA) and its long chain derivative,
arachidonic acid (AA) have pro-inflammatory actions
and promote adipogenesis and lipogenesis in vitro
and in vivo [12, 13]. Consequently, excess consump-
tion of omega-6 relative to omega-3 fatty acids would
be expected to be associated with increased incidence
of inflammatory conditions, increased adiposity and
heightened risk of cardiometabolic diseases.
The opposing roles of the omega-3 and omega-6
fatty acids has particular relevance due to a substantial
increase in the intake of the omega-6 essential fatty
acid, LA, in the Western diet over the past few de-
cades, with very little change in the intake of omega-3
PUFA. The ratio of LA:ALA in typical Western diets
has been reported at ~ 8–10:1 [14, 15] or higher [16],
which is substantially higher than the proposed ‘ideal’
ratio of ~ 1–2:1 based on levels required to achieve
maximal conversion of ALA to its longer chain deriva-
tives [17–19]. Previous studies have shown that the
high omega-6:omega-3 ratio in the modern Western
diets is reflected in the blood and tissue fatty acid pro-
files of pregnant and lactating women, as well as
breast milk [13], however, the effect of perinatal ex-
posure to an increased omega-6:omega-3 PUFA ratio
remains unclear. Massiera [20] demonstrated that in-
creasing omega-6 PUFA intake induced a gradual en-
hancement in fat mass over generations. However, the
level of LA (~ 19% energy) and LA:ALA ratio (28:1) in
their study were much higher than those found in typ-
ical Western diets, and the impact of different dietary
fat levels was not evaluated. In addition, no studies to
date have examined the effects of an increased mater-
nal omega-6:omega-3 ratio on maternal, placental and
fetal outcomes before birth.
The aim of the current study was to determine the ef-
fects of increasing the LA:ALA ratio (9:1 vs 1:1.5), in the
diet of rats, on maternal weight gain, placental and fetal
growth and the expression of lipogenic and adipokine
genes in maternal and fetal liver and maternal adipose
tissue. To determine any additive effects of altering the
maternal dietary LA:ALA ratio each diet was fed at
either 18% fat w/w, to reflect dietary recommendations of
fat intake [21], or at a higher fat content of 36% fat w/w.
Materials and methods
Animals
All animal procedures were performed in accordance
with the Animals (Scientific Procedures) Act 1986 under
Home Office licence and were approved by the Animal
Ethics Committee of the University of Nottingham, UK.
Virgin female Wistar rats (n = 24; 75-100 g; Charles
River, UK) were housed on wood shavings in individually
ventilated cages under a 12 h light/12 h dark cycle at a
temperature of 20–22 °C and had ad libitum access to
food and water throughout the experiment. Animals
were pair housed from the start of the experiment until
mating, after confirmation of conception animals were
individually housed until completion of the experiment.
Female rats were allowed to acclimatise to the unit for
1–2 weeks, during which time they were fed on standard
laboratory chow (2018 Teklad Global 18% Protein Ro-
dent Diet, Harlan Laboratories, UK). After acclimatisa-
tion, a tail vein blood sample was taken from each
animal for the determination of fatty acid status. The
rats were then randomly assigned to one of 4 dietary
groups, details of which are provided below. Animals
were maintained on their allocated diet for a four week
‘feed-in’ period after which they were mated. Conception
was confirmed by the presence of a semen plug and this
was recorded as day 0 of pregnancy. Average time in
mating pairs was 2.5 days and all but one female con-
ceived within their first oestrus cycle housed with the
male. Female rats remained on their respective diets
until day 20 of gestation (full term = 22 days) at which
time rat dams were euthanised by CO2 asphyxiation and
cervical dislocation and fetuses by cervical dislocation
and exsanguination for collection of maternal, fetal and
placental tissues. All female rats were weighed and had
feed intake measured daily throughout the experiment
and protein intake was estimated based on the protein
content of the experimental diets.
Diets
Diets were designed to provide either a high (9:1, high
LA) or low (1:1.5 low LA) ratio of LA to ALA, achieved
by altering the amounts of flaxseed and sunflower oil in-
cluded in the fat component of the feed. The levels of
saturated fatty acids (SFA) and monounsaturated fatty
acids (MUFA) were comparable in all diets, achieved by
adjusting the amounts of coconut (SFA source) and
macadamia (MUFA source) oils in the diets. For each
level of LA, diets containing either 18% or 36% fat by
weight were developed. This resulted in four experimen-
tal diets; high LA (18% fat), high LA (36% fat), low LA
(18% fat) and low LA (36% fat) (n = 5–7 per dietary
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group). The list of ingredients and final fatty acid com-
position of the four experimental diets is presented in
Table 1 and Table 2 respectively. Protein content of ex-
perimental feeds was analysed using a Thermo Scientific
nitrogen (N)/protein analyser (Flash EA1112). %N was
directly measured and protein (%) was estimated under
the assumption of a 16% N content of proteins.
Blood sample and tissue collection
Blood samples were collected from dams prior to the
start of the experiment and after the 4 week ‘feed-in’
period (tail vein) and at day 20 of gestation (cardiac
puncture following CO2 asphyxiation and cervical dis-
location). Truncal blood samples were also collected
from two randomly selected male and two randomly
selected female fetuses from each litter at this time. The
whole blood samples (~ 30 μl) were spotted onto PUFA-
coat™ dried blood spot (DBS) collection paper [22],
allowed to dry at room temperature and were then
stored at − 20 °C for subsequent fatty acid analysis. Ma-
ternal tissues were weighed and samples of liver and
retroperitoneal adipose tissue were collected. All fetuses
were weighed and sexed via measurement of anogenital
distance. Fetal liver and placentas were weighed and
samples of selected male placental and liver samples
were collected. All tissue samples were snap-frozen in li-
quid nitrogen and stored at − 80 °C until determination
of gene expression by reverse transcriptase quantitative
PCR (RT-qPCR). Male fetuses selected for collection of
tissue samples also had tail samples collected for
sex-genotyping by PCR for the SRY gene [23]. Any
samples found to be female or inconclusive (n = 5) were
not included in hepatic gene expression analyses.
Lipid extraction
Total lipids were extracted from male placental tissue
with chloroform/isopropanol (2:1 v/v), an adapted
method from Folch [24]. Briefly, ~ 300 mg of crushed
frozen placenta was weighed out and 2ml of 0.9% saline
was added. The solution was homogenised on ice, 3 ml
of isopropanol was added and vortexed and the solution
was left to stand for 5 min. After this, 6 ml of chloroform
was added and the solution was shaken, centrifuged and
the chloroform (bottom phase) containing the lipid was
transferred into a fresh tube. This was dried under nitro-
gen and resuspended in chloroform/methanol (9:1 v/v)
and 20 μl of the sample was then spotted onto PUFA-
coat™ DBS collection paper [22], allowed to dry at room
temperature and stored at − 20 °C for subsequent fatty
acid analysis.
Fatty acid methylation and analysis
Fatty acid composition in maternal and fetal DBS were
determined as previously described [22]. Briefly, whole
DBS samples were directly transesterified with 2 ml of
1%H2SO4 in methanol at 70 °C for 3 h. Samples were
allowed to cool and the fatty acid methyl esters (FAME)
were then extracted with heptane and transferred into a
glass vial containing anhydrous sodium sulphate
(Na2SO4) as a desiccant. Samples were separated and
analysed by a Hewlett-Packard 6890 gas chromatograph
(GC) equipped with a capillary column (30 m × 0.25
mm) coated with 70% cyanopropyl polysilphenylene-si-
loxane (BPX-70) (0.25 μm film thickness) which was fit-
ted with a flame ionization detector (FID). Helium was
utilised as the carrier gas and the split ratio was set at
20:1. Injector temperature was set at 250 °C and FID
Table 1 Ingredients in the Experimental Diets
Component Amount (g/100 g diet)
High LA
(18% Fat)
High LA
(36% Fat)
Low LA
(18% Fat)
Low LA
(36% Fat)
Casein 16.0 16.0 16.0 16.0
Cornflour 31.8 20.0 31.8 20.0
Sucrose 16.0 10.0 16.0 10.0
Cellulose 15.6 15.6 15.6 15.6
Mineral Mixa 1.8 1.8 1.8 1.8
Vitamin Mixa 0.4 0.4 0.4 0.4
Choline
Chloride
0.2 0.2 0.2 0.2
Methionine 0.4 0.4 0.4 0.4
Flaxseed Oil 0.9 1.7 4.2 8.5
Sunflower Oil 6.6 13.1 0.8 1.7
Macadamia
Oil
6.9 13.8 9.5 19.0
Coconut Oil 3.4 6.9 3.2 6.3
Total Fat 17.8 35.6 17.8 35.5
LA linoleic acid. aComposition of vitamin and mineral mixes based on AIN-76
formulation [50]
Table 2 Fatty Acid Composition of the Experimental Diets
Fatty Acid Amount (% of total lipids)
High LA
(18% Fat)
High LA
(36% Fat)
Low LA
(18% Fat)
Low LA
(36% Fat)
Total SFA 20.7 20.3 21.1 20.0
Total TFA 0.1 0.1 0.1 0.1
Total MUFA 48.8 49.0 53.3 54.9
Total Omega-6 (LA only) 27.3 27.4 11.1 10.5
Total Omega-3 (ALA only) 3.1 3.2 14.4 14.4
Total PUFA 30.4 30.6 25.5 25.0
LA:ALA Ratio 9.0 9.0 0.75 0.75
ALA %Energy 1.2 2.0 5.6 9.1
LA %Energy 10.5 17.3 4.3 6.7
LA linoleic acid, SFA saturated fatty acids, TFA trans fatty acids, MUFA
monounsaturated fatty acids, ALA alpha-linolenic acid, PUFA, polyunsaturated
fatty acids
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temperature at 300 °C. FAMEs were identified in un-
known samples based on the comparison of retention
times with an external lipid standard (Standard 463,
Nu-check prep Inc., MN, USA) using Agilent Chemsta-
tion software. Individual fatty acid content was calcu-
lated based on peak area and response factors
normalised to total fatty acid content and expressed as a
percentage of total fatty acids across lipid classes.
Isolation of RNA, cDNA synthesis and reverse
transcription quantitative real-time PCR (RT-qPCR)
RNA was isolated from crushed snap-frozen samples
of ~ 25 mg of liver using the Roche High Pure Tissue
kit (Roche Diagnostics Ltd., UK). Adipose RNA was
extracted using MagNA lyser green beads and instru-
ment (Roche Diagnostics Ltd.) in combination with
the RNeasy Mini Kit (QIAGEN Ltd., UK) with the
following modifications. Between 100 and 150 mg of
snap frozen tissue was homogenised using green
beads in 600 μl Buffer RTL (including β-mercap-
toethanol), the sample was centrifuged for 3 min at
8000 rpm and the resulting infranatant was trans-
ferred into a fresh tube. The remaining tissue sample
was homogenised in a further 350 μl of lysis buffer,
centrifuged as before and this infranatant was com-
bined with that from the initial extraction. This ex-
tract was centrifuged for 5 min at 13000 rpm, cleared
lysate removed and mixed with an equal volume of
70% ethanol and transferred to an RNeasy column
and from this point the standard manufacturer’s
protocol was applied. RNA concentration was deter-
mined using a Nanodrop 2000 (Thermo Scientific)
and RNA quality was evaluated by agarose gel elec-
trophoresis. cDNA was synthesised using a Rever-
tAid™ reverse transcriptase kit (Thermo Fisher
Scientific, UK) with random hexamer primers.
Lipogenic pathway and adipokine target genes
included; peroxisome proliferator-activated receptor
gamma (Pparg), sterol regulatory element-binding pro-
tein (variant 1c) (Srebf1), fatty acid synthase (Fasn), lipo-
protein lipase (Lpl) and leptin (Lep), with β-actin (Actb)
as the housekeeper (Table 3). Adipocyte and hepatic
gene expression was quantified using SYBR Green
(Roche Diagnostics) in a Light-Cycler 480 (Roche Diag-
nostics). Samples were analysed against a standard curve
of a serially diluted cDNA pool to produce quantitative
data and expression was normalised to the housekeeping
gene using LightCycler® 480 software (version 1.5.1) as
previously described [25]. The expression of the house-
keeper was not different between treatment groups.
Statistical analysis
Data are presented as mean ± SEM. Data were ana-
lysed using the Statistical Package for Social Sciences
(Version 24, SPSS Inc.). The effect of maternal dietary
fatty acid ratio and maternal dietary fat content on
maternal dependant variables was assessed using a
two-way ANOVA, with dietary fat level and LA:ALA
ratio as factors. Where longitudinal data was analysed,
as with maternal feed, protein and energy intake as
well as maternal bodyweight, the impact of maternal
dietary fat level and LA:ALA ratio was analysed using
a two-way repeated-measures ANOVA. Fetal data
were analysed using a two-way ANOVA, separating
males and females, with maternal dietary LA:ALA ra-
tio and fat content as factors. The experiment was
designed to detect a 0.5 g difference in fetal weight
with a power of 0.8, a value of P < 0.05 was consid-
ered to be statistically significant and the dam was
used as the unit of analysis.
Results
Maternal food intake
Dams receiving the 36% fat diets had a significantly
lower food intake in the 4 weeks prior to mating in-
dependent of the LA:ALA ratio (P < 0.01). During
pregnancy there was no effect of dietary fat content
or fatty acid ratio on maternal food intake although,
as expected, food intake in all groups increased as
pregnancy progressed (P < 0.05; Fig. 1a). Energy intake
was similar between groups prior to pregnancy. Dur-
ing gestation energy intake was higher in dams con-
suming the 36% fat diets, irrespective of dietary
LA:ALA ratio (P < 0.01). Similar to food intake, en-
ergy intake also increased with increasing gestational
age in all dietary groups (P < 0.05; Fig. 1b). Protein in-
take was lower in the 36% fat groups when compared
to the 18% fat groups prior to mating (P < 0.001) and
throughout gestation (P < 0.01). Protein intake was
relatively consistent for the 4 weeks prior to mating
but increased with increasing gestational age during
pregnancy (P < 0.05) (Fig. 1c). There was no signifi-
cant effect of dietary LA:ALA ratio on food, energy
or protein intake at any time during the study.
Maternal fatty acid profile
There were no differences in the blood fatty acid profiles
of the rats assigned to the different experimental diets
before commencement of the dietary intervention, and
the proportions of SFA, MUFA, omega-6 (Fig. 2a) and
omega-3 PUFA (Fig. 2b) were all similar between groups.
After 4 weeks on their respective diets, however, mater-
nal fatty acid profiles were significantly different between
treatments and largely reflected the composition of the
experimental diets. Whole blood proportions of LA
and AA were lower in the low LA compared to the
high LA groups (P < 0.001; Fig. 2c). Dams fed the low
LA diets had four-fold higher ALA levels compared
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to the high LA groups, independent of dietary fat
content (P < 0.001). Whole blood proportions of DHA
were also significantly higher (P < 0.01) in dams fed
the low LA diet, but the magnitude of this effect was
relatively small (1.3-fold; Fig. 2d). The proportion of
EPA was ten-fold higher and DPA two-fold higher in
dams consuming the low LA diets. However, relative
EPA and DPA levels were both lower in the low LA,
36% fat diet group compared to the low LA, 18% fat
group, but were not different between the 36 and
18% fat diet levels in rats fed the high LA diets (EPA:
fat content, P < 0.05; fatty acid ratio, P < 0.001; inter-
action, P < 0.05. DPA: fat content, P < 0.01; fatty acid
ratio, P < 0.001; interaction, P < 0.05) (Fig. 2d). There
was no effect of dietary fat content on the propor-
tions of EPA and DPA at the end of the experiment.
The remaining effects of both total fat level and diet-
ary fat ratio on maternal fatty acid profile were, how-
ever, maintained until the end of the study (day 20 of
gestation) (Fig. 2e and f ).
Maternal weight and body composition
Bodyweight immediately prior to commencement of feed-
ing the experimental diets was not different between rats
assigned to the 4 respective treatment groups (Fig. 3).
There was no effect of either LA:ALA ratio or dietary fat
content on maternal weight prior to mating or throughout
pregnancy (Fig. 3) and maternal weight at day 20 of preg-
nancy was similar between groups (Fig. 3; Table 4). Dams
in the low LA groups had larger hearts relative to body
weight at day 20 of gestation (P < 0.05), but there were no
differences in the relative weight of other major organs,
including the liver, kidney, lung and brain, between groups
(Table 4). There were no significant differences in the mass
of the gonadal and retroperitoneal fat depots between ex-
perimental groups (Table 4). There were also no differences
in the expression of any of the genes measured in the hep-
atic or adipose tissue between dietary groups (Table 4).
Placental fatty acid profile
The placental fatty acid profile at day 20 of gestation
(Fig. 4a and b) was similar to dam whole blood fatty acid
profile at this time point (Fig. 2e and f). Placentas of
dams fed a high LA diet had 1.3 fold higher LA, AA and
total omega-6 PUFA irrespective of dietary fat content
(P < 0.001; Fig. 4a). Conversely, total omega-3 PUFA (1.9
fold), ALA (5.5 fold) and EPA (6.5 fold) proportions
were increased in placentas of dams consuming a low
LA diet, regardless of dietary fat content (P < 0.001). The
relative levels of DPA in the placenta were higher in
dams receiving a low LA diet but were also influenced
by total dietary fat content, such that the proportion of
DPA was lower in dams fed the 36% vs. 18% fat diets in
the low LA ratio groups only (fat content, P < 0.01; fatty
acid ratio, P < 0.001; interaction, P < 0.01). DHA propor-
tions were also influenced by both the fat content and
LA:ALA ratio of the diet, such that dams exposed to the
low LA diets had higher placental DHA compared to
those fed on high LA diets (P < 0.001) and dams fed the
36% fat diet had higher relative levels of placental DHA
compared to dams consuming either of the 18% fat diets
(P < 0.05; Fig. 4b). Placental total MUFA proportions
were higher in the low LA compared to the high LA
groups (P < 0.001) but were not affected by dietary fat
content. Placental SFA were lower in dams exposed to a
low LA diet (P < 0.05) as well as in dams exposed to a
high (36%) fat diet (P < 0.05), however the magnitude of
this difference was very small (Fig. 4a).
Table 3 Primer sequences used for the determination of gene expression by RT-qPCR
Target Genes Sequence (5′-3′) Amplicon Size Accession Number
Fasn FWD: TGCTCCCAGCTGCAGGC 107 NM_017332
REV: GCCCGGTAGCTCTGGGTGTA
Lpl FWD: TTCCTGGATTAGCAGACTCTGTGT 89 NM_012598
REV: TCCTGTCACCGTCCATCCAT
Pparg FWD: CTCAGTGGAGACCGCCCA 75 NM_013124
REV: CAGGGCCTGCAGCAGGT
Srebf1 FWD: GATTGCACATTTGAAGACATGCTT 95 NM_001276708
REV: CCTGTCTCACCCCCAGCATA
Lep FWD: AGACCATTGTCACCAGGATCAAT 89 NM_013076
REV: CCCGGGAATGAAGTCCAAA
Actb FWD: GACCCAGATCATGTTTGAGACCTT 79 NM_031144
REV: AGAGGCATACAGGGACAACACA
Fasn fatty acid synthase, Lpl lipoprotein lipase, Pparg peroxisome proliferator-activated receptor gamma, Srebf1 sterol regulatory element-binding protein 1, Lep
leptin, Actb beta-actin
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Fetal whole blood fatty acid profile
There was no effect of sex on fetal fatty acid profile
and so male and female samples were combined for
subsequent analysis. Blood ALA (five-fold) and EPA
(seven-fold) were higher in fetuses of dams exposed
to the low LA diets. However, there was a significant
interaction between maternal dietary LA:ALA ratio
and maternal dietary fat content for these fatty acids,
such that increasing dietary fat content from 18 to
36% fat was associated with relatively higher ALA (fat
content, P < 0.001; fatty acid ratio, P < 0.001; inter-
action, P < 0.001) and lower EPA levels (fat content,
P = 0.721; fatty acid ratio, P < 0.001; interaction, P <
0.05) in the low LA groups only. DPA (three-fold)
and DHA (1.3-fold) blood proportions were also in-
creased in fetuses of dams exposed to the low LA di-
ets, independent of dietary fat content (P < 0.001; Fig.
4d). Conversely, fetuses of dams consuming the low
LA diets had relatively lower circulating LA (1.2-fold)
and AA (1.4-fold) compared to fetuses of dams fed
high LA diets (P < 0.001; Fig. 4c). Interestingly, fetal
LA proportions were also influenced by dietary fat
content, such that fetuses of dams consuming the
36% fat diets had higher relative circulating LA (P <
0.001) levels compared to fetuses of dams fed the
18% fat diet. Fetal blood MUFA were influenced by
both maternal dietary LA:ALA ratio and dietary fat
content. Thus, fetuses of dams exposed to a low LA
diet exhibited elevated MUFA proportions compared
to high LA groups (P < 0.001) and fetuses of dams ex-
posed to a 36% fat diet had proportionately lower cir-
culating MUFA levels compared to fetuses of dams
fed the 18% fat diets (P < 0.001; Fig. 4c).
Fetal and placental weight and hepatic gene expression
The impact of maternal dietary fat content and
LA:ALA ratio on placental and fetal weights was dif-
ferent for males and females. Thus, placental weight
was higher in male, but not female, fetuses of dams
consuming low LA diets (P < 0.05). In females, how-
ever, fetuses of dams consuming the low LA diet were
heavier (P < 0.01) than those of dams fed the high LA
diets, irrespective of dietary fat content, this effect
was not seen in males. Despite these differences in
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Fig. 1 Maternal average daily (a) food intake, (b) energy intake and
(c) protein intake before mating and up to day 20 of gestation fed
on either a high LA (18% fat) diet (closed circles), high LA (36% fat)
diet (open circles), low LA (18% fat) diet (closed squares) and a low
LA (36% fat) diet (open squares). Values are means ± SEM and n =
5–7 per group. The effects of dietary fatty acid ratio and dietary fat
content were determined using a two-way repeated measures
ANOVA. * indicates a significant effect of dietary fat content (** P <
0.01, *** P < 0.001)
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fetal and placental weights, however, the fetal-
placental weight ratio was not different between treat-
ment groups in either males or females. Female, but
not male, fetuses of dams consuming 36% fat diets
also had smaller livers relative to bodyweight, inde-
pendent of the dietary LA:ALA ratio (P < 0.05;
Table5). Hepatic gene expression was not assessed in
female fetuses, but hepatic mRNA expression of Fasn,
Lpl, Pparg and Srebf1 in male fetuses was not differ-
ent between groups (Table 6).
Discussion
The results of the current study demonstrate that
varying the fat content and LA:ALA ratio in the diet
during pregnancy results in significant shifts in the
fatty acid profile of the dam, placenta and fetus in
A B
C D
E F
Fig. 2 Maternal whole blood fatty acids profile at (a/b) baseline (c/d) after 4 weeks on experimental diet and (e/f) at day 20 of gestation. Values
are means ± SEM and n = 5–7 per group. The effects of dietary fatty acid ratio and dietary fat content were determined using a two-way ANOVA
(*P < 0.05, **P < 0.01, ***P < 0.001). † indicates a significant interaction between dietary fat content and LA:ALA ratio (P < 0.05)
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late pregnancy with dietary LA:ALA ratio eliciting po-
tentially sex-specific effects on placental and fetal
weights. Importantly, these effects occurred in the ab-
sence of any impact of dietary LA:ALA ratio on ma-
ternal energy intake, bodyweight or fat deposition.
Doubling the fat content of these experimental diets
had the expected impact on maternal food and energy
intake but was not associated with any significant al-
terations in maternal, placental or fetal weights or
maternal fat deposition.
Maternal fatty acid profiles after 4 weeks on the ex-
perimental diets, and at the end of pregnancy, confirmed
that the experimental diets had the desired effect on ma-
ternal fatty acid composition. Consistent with previous
studies, increasing dietary ALA content had the greatest
effect on maternal ALA and EPA proportions whereas
relative DHA levels were only slightly higher than con-
trols [26–29]. However, despite the significant shifts in
maternal fatty acid profiles, and differences in energy in-
take between dams in the 36 and 18% fat groups during
gestation, we found no difference in maternal body
weight or fat deposition between these groups. This was
unexpected, previous studies with comparable fat con-
tents have reported significant increases in maternal
bodyweight and fat mass in dams fed on diets containing
higher amounts of total fat [30, 31]. Consistent with
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Fig. 3 Maternal weight gain of rats during pre-feeding and up to
day 20 of gestation fed on either a high LA (18% fat) diet (closed
circles), high LA (36% fat) diet (open circles), low LA (18% fat) diet
(closed squares) and a low LA (36% fat) diet (open squares). Values
are means ± SEM and n = 5–7 per group. The effects of dietary fatty
acid ratio and dietary fat content were determined using a two-way
repeated measures ANOVA and no significant differences were
found between groups
Table 4 Maternal organ weights and gene expression
High LA (18% Fat) High LA (36% Fat) Low LA (18% Fat) Low LA (36% Fat)
Bodyweight (g) 376.4 ± 4.65 384.41 ± 11.00 384.34 ± 16.90 353.63 ± 9.55
Heart (% BW) 0.25 ± 0.01a 0.26 ± 0.01a 0.28 ± 0.02b 0.28 ± 0.01b
Lungs (% BW) 0.37 ± 0.05 0.36 ± 0.03 0.38 ± 0.05 0.36 ± 0.04
Kidney (%BW) 0.53 ± 0.02 0.50 ± 0.01 0.53 ± 0.02 0.54 ± 0.02
Liver (% BW) 4.01 ± 0.14 3.95 ± 0.07 4.10 ± 0.10 3.94 ± 0.10
Brain (% BW) 0.47 ± 0.02 0.46 ± 0.01 0.50 ± 0.03 0.53 ± 0.02
Gonadal Fat (% BW) 2.95 ± 0.03 2.38 ± 0.18 2.33 ± 0.18 3.04 ± 0.58
Retroperitoneal Fat (% BW) 1.18 ± 0.17 1.18 ± 0.17 1.18 ± 0.011 1.79 ± 0.24
Liver mRNA Expression
Fasn 5.51 ± 1.33 2.83 ± 0.59 6.08 ± 2.31 4.24 ± 1.21
Lpl 3.13 ± 1.00 2.39 ± 0.75 2.52 ± 0.80 1.74 ± 0.71
Pparg 5.81 ± 1.85 2.30 ± 0.77 3.38 ± 0.78 2.09 ± 0.73
Srebf1 1.33 ± 0.31 1.20 ± 0.22 1.23 ± 0.50 2.67 ± 1.14
Retroperitoneal Fat mRNA Expression
Fasn 0.12 ± 0.05 0.07 ± 0.04 0.15 ± 0.05 0.13 ± 0.07
Lpl 2.18 ± 0.66 1.82 ± 0.81 2.18 ± 0.72 1.48 ± 0.16
Pparg 1.15 ± 0.47 1.40 ± 0.59 1.76 ± 0.48 1.03 ± 0.17
Srebf1 1.17 ± 0.40 1.16 ± 0.41 1.38 ± 0.42 1.11 ± 0.13
Lep 2.59 ± 0.67 2.73 ± 0.99 2.31 ± 0.69 1.83 ± 0.34
Data are presented as mean values ± SEM (n = 4–6 per group). LA linoleic acid, BW bodyweight, mRNA messenger ribonucleic acid, Fasn fatty acid synthase, Lpl
lipoprotein lipase, Pparg peroxisome proliferator-activated receptor gamma, Srebf1 sterol regulatory element-binding protein 1, Lep leptin. Mean values with unlike
superscript letters were significantly different (P < 0.05)
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previous studies [32], dams fed on the 36% fat diets in
this study reduced their feed intake to compensate for
the higher energy density of the feed and it may be that
this adaptive response was sufficient to prevent excessive
weight gain and fat deposition in dams fed the higher fat
diet.
Our finding that placental and fetal fatty acid profiles
were similar to those in the dams was consistent with
our hypothesis that variations in maternal fatty acid pro-
file would be reflected in the fetal compartment. Thus,
our results confirm that shifts in maternal dietary fatty
acid intake are associated with corresponding shifts in
fetal fatty acid supply. It is, however, important to note
that the relative proportions of some fatty acids, most
notably LA and MUFA, in the fetal compartment also
appeared to be influenced by total dietary fat content,
independent of the dietary fat ratio. This effect was not
observed to the same extent for maternal and placental
fatty acid profiles and implies that not only the ratio, but
also absolute amounts of fatty acids is a key determinant
of placental fatty acid transfer. Our finding that fetal, but
not maternal or placental, LA proportions were higher
in the 36% fat vs 18% fat groups implies that placental
LA transfer is favoured as dietary fat content increases.
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Fig. 4 Placental (a/b) and fetal whole blood (c/d) fatty acid profile at gestational day 20. Values are means ± SEM and n = 10–14 per group. The
effects of maternal dietary fatty acid ratio and maternal dietary fat content were determined using a two-way ANOVA (*P < 0.05, **P < 0.01, ***P <
0.001). † indicates a significant interaction between dietary fat content and LA:ALA ratio (P < 0.05)
Table 5 Fetal and placental weights and fetal organs
Sex High LA (18% Fat) High LA (36% Fat) Low LA (18% Fat) Low LA (36% Fat)
Fetal bodyweight (g) Male 3.33 ± 0.04 3.25 ± 0.08 3.55 ± 0.09 3.32 ± 0.09
Female 3.01 ± 0.06a 2.95 ± 0.09a 3.36 ± 0.12b 3.21 ± 0.08b
Placenta weight (g) Male 0.50 ± 0.02a 0.52 ± 0.03a 0.56 ± 0.03b 0.61 ± 0.02b
Female 0.48 ± 0.02 0.48 ± 0.04 0.52 ± 0.02 0.51 ± 0.03
Fetal liver weight (% BW) Male 7.43 ± 0.42 6.52 ± 0.11 6.81 ± 0.58 6.97 ± 0.25
Female 7.51 ± 0.38a 6.99 ± 0.29b 7.73 ± 0.22a 6.86 ± 0.28b
Fetal-placental ratio Male 6.79 ± 0.24 6.37 ± 0.33 6.51 ± 0.41 5.99 ± 0.41
Female 6.38 ± 0.32 6.35 ± 0.48 7.72 ± 0.96 6.13 ± 0.36
Data are presented as mean values ± SEM (n = 4–6 per group). LA linoleic acid, BW bodyweight. Mean values with unlike superscript letters were significantly
different (P < 0.05)
Draycott et al. Nutrition & Metabolism            (2019) 16:1 Page 9 of 12
Placental capacity to store fatty acids as triglycerides has
been well documented [33], and placental triglyceride
levels are increased in conditions where maternal circu-
lating triglyceride and fatty acid concentrations are high
[34]. However, this storage capacity is limited and in
cases of excess maternal dietary fat has the potential to
result in a greater proportion of fatty acids being trans-
ferred from maternal to fetal circulation. One possibility,
therefore, is that the capacity of the placenta for LA
storage is exceeded in the 36% fat groups in our current
study and that this resulted in a greater amount of this
fatty acid being transferred to the fetal compartment. In
contrast to LA, however, fetal MUFA proportions in the
current study were lower in the 36% fat compared to the
18% fat groups. Thus, the results of our study indicate
that the effect of increased dietary fat content on placen-
tal fatty acid transfer varies substantially between indi-
vidual fatty acids.
That the human placenta preferentially transfer spe-
cific fatty acids over others, following the hierarchy of
AA>DHA >ALA>LA > oleic acid, has been previously
demonstrated [35]. The findings from the present study
suggest that this selective transfer effect may be exacer-
bated in the presence of an increased dietary fat load,
such that the higher total amounts of LA and ALA in
the 36% fat diets lead to greater transfer of LA and ALA
to the fetal compartment, at the expense of MUFA, par-
ticularly oleic acid. If this is the case, it would imply that
the quality of dietary fat intake during pregnancy may be
more important, and thus have a greater potential to in-
fluence fetal growth and development, at higher levels of
total dietary fat intakes. The fatty acid data in our study
are expressed as a proportion of total lipids rather than
absolute concentrations, and the relatively small propor-
tionate change in fetal LA could translate into a much
greater, and physiologically relevant, change in absolute
concentrations.
In contrast to previous studies, we found no effect of
maternal total fat intake on placental or fetal body-
weight, and our results in fact suggest that maternal
LA:ALA ratio had a greater effect on these measures.
The increased placental weight of male fetuses in the
low LA groups suggests that an increase in maternal
omega-3 status may potentially increase placental
growth. One possibility for this increase in weight is that
omega-3 fatty acids are preferentially deposited in the
placenta. This, however, seems unlikely given that previ-
ous studies have suggested that while there is preferen-
tial placental uptake of DHA from the maternal
circulation, the majority is transferred across the pla-
centa to the fetal circulation [35, 36]. In addition, a con-
siderable amount of omega-3 fatty acids (~ 75 mg)
would have to accumulate in the placenta to solely ac-
count for the difference in placental weight between
high and low LA groups, making it unlikely that this
mechanism could fully account for the observed increase
in placental weight. An alternative possibility is that
omega-3 PUFA, in particular DHA, acted to promote
placental growth. Why the increased placental weight in
our study was only seen in male placentas is not com-
pletely clear, however, female placental weight appeared
to follow the same trajectory but did not reach statistical
significance. Differences in gene expression between
male and female placentas have been documented [37].
Given that the effects on placental weight only reached
significance in males, it is interesting that maternal con-
sumption of the low LA diet was associated with in-
creased fetal weight only in females. Maternal omega-3
LCPUFA supplementation during pregnancy has been
associated with increases in birth weight in human ran-
domised controlled trials [39]. However, this is generally
considered to be secondary to an increase in the dur-
ation of gestation and therefore cannot explain the
higher fetal weights observed in this study, since all fe-
tuses were weighed at the same gestational age. There
are, however, previous reports indicating that upregula-
tion of omega-3 LCPUFA-responsive genes following
maternal omega-3 LCPUFA supplementation is more
pronounced in female compared to male placentas in
humans, and is associated with increases in infant birth
weight, but not placental weight [38]. Our finding of
lower female fetal liver weight in the 36% fat groups is
consistent with some [40], but not all [41, 42], studies
that have previously reported the effects of maternal
high fat diets on neonatal liver weight. Whether the re-
duced liver weight in fetuses of dams consuming the
high fat diet persists after birth, and whether it has func-
tional consequences for hepatic metabolism, remain to
be determined.
It was interesting that despite the significant changes
in the fatty acid profiles of both dams and fetuses, no
changes in maternal (hepatic and adipose tissue) or fetal
(hepatic) expression of lipogenic genes were observed in
this study. This was despite evidence from previous
studies that omega-3 PUFA can supress, while omega-6
PUFA can promote, expression of Srebf1 and down-
stream lipogenic genes [43, 44]. It is possible, however,
Table 6 Fetal Liver Gene expression
High LA
(18% Fat)
High LA
(36% Fat)
Low LA
(18% Fat)
Low LA
(36% Fat)
Fasn 0.59 ± 0.19 0.30 ± 0.03 0.37 ± 0.06 0.49 ± 0.13
Lpl 1.79 ± 0.55 1.41 ± 0.27 1.11 ± 0.33 1.17 ± 0.46
Pparg 0.36 ± 0.12 0.42 ± 0.05 0.34 ± 0.07 0.48 ± 0.16
Srebf1 1.21 ± 0.61 0.65 ± 0.30 0.27 ± 0.04 0.82 ± 0.30
Data are presented as mean values ± SEM (n = 4–6 per group). LA linoleic acid,
Fasn fatty acid synthase, Lpl lipoprotein lipase, Pparg peroxisome proliferator-
activated receptor gamma, Srebf1 sterol regulatory element-binding protein 1
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that any changes in maternal gene expression and corre-
sponding increases in lipogenesis could be masked by
the normal physiological adaptations that occur during
pregnancy, particularly between day 19 and 20 of gesta-
tion where the pregnant rat experiences a marked in-
crease in total body fat mass [45]. Similarly, due to the
immaturity of hepatic signalling pathways within the
fetus, changes in gene expression occurring as a result of
altered maternal dietary LA:ALA ratio may be too subtle
to be detected.
In conclusion, we have demonstrated that both the
total amount of fat and the ratio of LA and ALA in the
maternal diet have significant effects on placental and
fetal weight, supporting the hypothesis that the quality,
as well as the quantity, of fat in the maternal diet can
impact on fetal growth and development. Importantly,
the LA:ALA ratio in the current study was designed to
reflect that of typical Western diets of many countries,
and our results show that consuming this high LA diet
was associated with alterations in placental and fetal
weight in comparison to a LA:ALA ratio considered to
be ‘optimal’ for human nutrition [14]. The observed
changes in placental and fetal weight may contribute to
future metabolic and physiological function of the off-
spring, given the established association between re-
duced fetal and placental growth and increased future
risk of obesity and poor metabolic health [46–48]. How-
ever, further studies are required in order to determine
the longer-term impacts of maternal dietary LA;ALA ra-
tio and total fat load on the growth, body composition
and cardiometabolic health of the offspring. Human
studies that have assessed the potential implication of a
higher omega-6:omega-3 ratio and/or elevated maternal
omega-6 intakes on growth, body composition or meta-
bolic health of the children are also limited [49] and fur-
ther studies (or re-evaluation of existing studies) are
needed. The results of the current study have also dem-
onstrated that at least some of the effects of maternal
dietary fat load/LA:ALA ratio elicited sex-specific re-
sponses, which may in part be due to differences in the
placental response to omega-3 LCPUFA between male
and female placentas. Further research is required to as-
sess the placental responses to shifts in maternal dietary
fat content and composition in both males and females
and the “sex of the placenta” should be considered in
future studies.
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